Press & News

Press & News2021-02-03T22:33:26+00:00

Latest Articles

Browse a selection of ImaginAb press and news below.

912, 2019

ImaginAb Initiates Phase II Clinical Trial at Penn Medicine

ImaginAb, Inc., a clinical-stage immuno-oncology imaging company, announces it has initiated its Phase II clinical trial of its lead product, CD8 tracer 89Zr-Df-IAB22M2C, at Penn Medicine in Philadelphia, PA. Penn Medicine is one of the world’s leading academic medical centers.

Load More Posts
Go to Top